S.C. Heslinga

1.5k total citations
5 papers, 111 citations indexed

About

S.C. Heslinga is a scholar working on Rheumatology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S.C. Heslinga has authored 5 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 1 paper in Molecular Biology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in S.C. Heslinga's work include Spondyloarthritis Studies and Treatments (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). S.C. Heslinga is often cited by papers focused on Spondyloarthritis Studies and Treatments (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). S.C. Heslinga collaborates with scholars based in Netherlands and United States. S.C. Heslinga's co-authors include Vokko P. van Halm, Michael T. Nurmohamed, Alper M. van Sijl, Katalin Boér, Irene E. van der Horst‐Bruinsma, Judy Geissler, Thelma C. Konings, Otto Kamp, Karin van Leeuwen and Timo K. van den Berg and has published in prestigious journals such as Annals of the Rheumatic Diseases, Heart and Current Medicinal Chemistry.

In The Last Decade

S.C. Heslinga

4 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.C. Heslinga Netherlands	4	75	32	25	19	17	5	111
Luis M. Vilá United States	4	84 1.1×	61 1.9×	19 0.8×	11 0.6×	22 1.3×	4	123
Julien Rohmer France	6	30 0.4×	28 0.9×	13 0.5×	31 1.6×	16 0.9×	13	111
N. Vegas-Revenga Spain	6	79 1.1×	27 0.8×	22 0.9×	21 1.1×	5 0.3×	11	114
José Alfaro-Lozano Peru	7	87 1.2×	40 1.3×	7 0.3×	17 0.9×	7 0.4×	18	125
M.F. Vitale Italy	2	93 1.2×	37 1.2×	24 1.0×	21 1.1×	20 1.2×	2	124
Yih Chang Lin United States	7	86 1.1×	53 1.7×	12 0.5×	12 0.6×	22 1.3×	14	141
Tim Godfrey Australia	5	56 0.7×	30 0.9×	11 0.4×	22 1.2×	4 0.2×	7	92
Verónica Bellomio Argentina	6	122 1.6×	33 1.0×	20 0.8×	5 0.3×	26 1.5×	10	149
Pierre‐Edouard Gavand France	5	115 1.5×	66 2.1×	7 0.3×	8 0.4×	12 0.7×	8	144
Mette Yde Dam Denmark	6	52 0.7×	13 0.4×	34 1.4×	25 1.3×	26 1.5×	12	173

Countries citing papers authored by S.C. Heslinga

Since Specialization

Citations

This map shows the geographic impact of S.C. Heslinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.C. Heslinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.C. Heslinga more than expected).

Fields of papers citing papers by S.C. Heslinga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.C. Heslinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.C. Heslinga. The network helps show where S.C. Heslinga may publish in the future.

Co-authorship network of co-authors of S.C. Heslinga

This figure shows the co-authorship network connecting the top 25 collaborators of S.C. Heslinga. A scholar is included among the top collaborators of S.C. Heslinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.C. Heslinga. S.C. Heslinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Heslinga, S.C., Thelma C. Konings, M. Louis Handoko, et al.. (2021). Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation. Rheumatology International. 42(4). 683–688. 11 indexed citations

2.

Heslinga, S.C., Michael T. Nurmohamed, A. Gerards, et al.. (2016). SAT0416 Significantly Reduced Recurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis during Treatment with Golimumab. Annals of the Rheumatic Diseases. 75. 820–821.

3.

Heslinga, S.C., et al.. (2016). Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Heart. 102(10). 790–795. 78 indexed citations

4.

Heslinga, S.C., Alper M. van Sijl, Katalin Boér, Vokko P. van Halm, & Michael T. Nurmohamed. (2015). Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review. Current Medicinal Chemistry. 22(16). 1892–1902. 13 indexed citations

5.

Heslinga, S.C., Karin van Leeuwen, Judy Geissler, et al.. (2015). Study on the Protective Effect of the KIR3DL1 Gene in Ankylosing Spondylitis. Arthritis & Rheumatology. 67(11). 2957–2965. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact